Reason for request
Inclusion
Clinical Benefit
| Insufficient |
The actual benefit of CLIMASTON 0.5 mg/2.5 mg is insufficient for reimbursement by National Health Insurance in the Marketing Authorisation indication. |
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
W75jGAPBXZp8mMzH
